BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Data at SABCS and ASH Demonstrate Daiichi Sankyo Commitment to Advancing Science in Breast and Blood Cancer

  Updated data from the ongoing phase 1 study of DS-8201, an investigational HER2-targeting ADC, in HER2-positive metastatic breast cancer as well as patients with HER2 low-expressing breast cancer will be highlighted as a Spotlight Poster Discussion at SABCS.

  November 14, 2017

   · 

  8 min read
• BioCapital

  Akonni Biosystems Awarded NIH Grant to Support Commercialization of a Low-Cost, Simple, Rapid Point-of-Care Test for Tuberculosis and its Resistance to First-Line Drugs

  This grant in particular will help Akonni accelerate the commercialization of its proprietary TruArray MDR-TB test on its TruDx 3000 sample-to-answer diagnostic platform.

  November 14, 2017

   · 

  3 min read
• Genetown

  121nexus Launches Powerful Free Scan App to Dramatically Improve Medical Device and Pharmaceutical Supply Chain

  Recently demonstrated at the GS1 Healthcare Conference, the 121nexus scanner is now available free for iOS in the Apple App Store.

  November 14, 2017

   · 

  3 min read
• Business

  Aerpio Pharmaceuticals Announces Appointment of Michael Rogers as Chief Financial Officer

  Mr. Rogers has more than 25 years of experience in the biopharmaceutical industry, serving as Chief Financial Officer (CFO) of five publicly-traded healthcare companies.

  November 14, 2017

   · 

  3 min read
• Drug Development

  Proclara Biosciences Presents New Preclinical Data Supporting Development of GAIM-Based Therapies at Society for Neuroscience Annual Meeting

  The data demonstrate that GAIM-based therapies, including Proclara’s lead candidate, NPT088, and second generation candidate, NPT189, can reduce the accumulation and cell-to-cell transmission of multiple types of toxic protein aggregates in diseases caused by toxic protein buildup.

  November 14, 2017

   · 

  3 min read
• Business

  Cleveland BioLabs Reports Third Quarter 2017 Financial Results and Development Progress

  Cleveland BioLabs reported a net loss of $(1.3) million, excluding minority interests, for the third quarter of 2017, or $(0.11) per share, compared to a net gain, excluding minority interests, of $1.1 million, or $0.10 per share, for the same period in 2016.

  November 14, 2017

   · 

  15 min read
• Genetown

  Senscio Systems Awarded U.S. Patent for Pioneering Artificial Intelligence for Home Healthcare

  Senscio Systems today announced it was granted a U.S. Patent for the invention of a powerful artificial intelligence framework that enables people with chronic diseases to manage their health proactively and independently from home.

  November 14, 2017

   · 

  4 min read
• Business

  Ymir Genomics and the OHSU Knight Cancer Institute Announce Collaboration

  The collaboration will exploit Ymir’s proprietary urinary extracellular vesicle technology and the expertise of the Knight Cancer Institute supported OHSU Proteomics Shared Resource.

  November 14, 2017

   · 

  3 min read
• 

  Genetown

  Cambridge’s ImmusanT Nabs $40M

  The cash will fund a randomized Phase II clinical trial of escalating doses of Nexvax2 in celiac patients who possess the human leukocyte antigen-DQ2.5 (HLA-DQ2.5) immune recognition gene.

  November 14, 2017

   · 

  5 min read
• BioMidwest

  Baxter Declares Quarterly Dividend

  The dividend is payable on January 2, 2018, to stockholders of record as of December 1, 2017. The indicated annual dividend rate is $0.64 per share.

  November 14, 2017

   · 

  1 min read